10:30 | Macular edema secondary to acute retinal necrosis: therapeutic options and challenges | TUGAL-TUTKUN I | ||
10:40 | Discussion | |||
10:42 | Biologic agents breakthroughs: navigating controversies and challenges in uveitis treatment | NERI P | ||
10:52 | Discussion | |||
10:54 | The challenge of global imaging appraisal of HLA-A29 Birdshot Retinochoroiditis: the dual involvement | HERBORT C | ||
11:04 | Discussion | |||
11:06 | The challenge and outcome of long-term TNF-α-inhibition in Beheçt’s uveitis | TAKEUCHI M | ||
11:16 | Discussion | |||
11:18 | Glimpses and challenges in choroidal vasculitis: think outside the box | PAPASAVVAS I | ||
11:28 | Discussion | |||
11:30 | End of Session |